SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brumar89 who wrote (1303428)6/10/2021 3:51:46 PM
From: Bill1 Recommendation

Recommended By
FJB

  Read Replies (3) of 1574180
 
Was Trump right about hydroxychloroquine
all along? New study shows drug touted
by former president can increase
COVID survival rates by 200%

Daily Mail (UK), by Harriet Alexander

Original Article

A malaria drug which Donald Trump was condemned for hailing as a possible COVID-19 treatment can increase survival rates by up to 200 per cent, scientists say. Scientists found that, when ventilated patients with a severe version of COVID were given high doses of hydroxychloroquine with zinc, their survival rates could increase dramatically.(Snip) The former president had previously touted hydroxy as a potential miracle treatment, with scientists lining up to insist he was wrong to do so. Yet Trump's allies on Wednesday were highlighting the study, conducted by Saint Barnabas Medical Center in New Jersey on 255 patients.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News